APA (7th ed.) Citation

Tapia-Calle, G., Aguilar, G., Vaissiere, N., Truyers, C., Ylisastigui, P., Buntinx, E., . . . Cambre, S. Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: A non-inferiority randomised controlled trialResearch in context. Elsevier.

Chicago Style (17th ed.) Citation

Tapia-Calle, Gabriela, et al. Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S Co-administered with a Quadrivalent Standard-dose or High-dose Seasonal Influenza Vaccine: A Non-inferiority Randomised Controlled TrialResearch in Context. Elsevier.

MLA (9th ed.) Citation

Tapia-Calle, Gabriela, et al. Safety, Reactogenicity, and Immunogenicity of Ad26.COV2.S Co-administered with a Quadrivalent Standard-dose or High-dose Seasonal Influenza Vaccine: A Non-inferiority Randomised Controlled TrialResearch in Context. Elsevier.